Crypto-Linked ETFs Are 2022’s Biggest Losers With 60% Drawdowns
(Bloomberg) -- Crypto-flavored exchange-traded funds are cluttering the industry's worst-performing list so far this year.
The six worst-performing, non-leveraged ETFs in the $6.6 trillion arena in 2022 are all crypto-linked equity funds, according to data compiled by Bloomberg. The $63 million Global X Blockchain ETF (ticker BKCH) is the biggest loser with a year-to-date drop of 64%.
While crypto-linked ETFs have swelled in ranks over the past year, performance has been grim. Fading speculative fervor and tightening monetary policy has dragged Bitcoin lower by more than 30% this year, slamming the stocks of public companies involved with digital assets.
Read more: Tech and Crypto in Peril as Fed Ends Liquidity Binge: MLIV Pulse
The silver lining is that even as the number of funds has ballooned, inflows have been light -- minimizing the overall blow to portfolios, according to UBS.
“Crypto ETFs have proliferated like crazy over the past year, with more varieties and cheaper fees, but inflows have been miserable,” said James Malcolm, head of foreign exchange and crypto research at UBS. “So I don't think the overall impact on ordinary people's portfolios is material. This is still such a niche asset class, and the retail frenzy ended a year ago.”
The $32 million VanEck Digital Transformation ETF (DAPP) is a close second to BKCH with a 63% drawdown, followed by a 62% plunge in $63 million Bitwise Crypto Industry Innovators ETF (BITQ). The First Trust SkyBridge Crypto Industry and Digital Economy ETF (CRPT), the Viridi Cleaner Energy Crypto-Mining & Semiconductor ETF (RIGZ) and the Defiance Digital Revolution ETF (NFTZ) all follow with falls of 55% or more.
More stories like this are available on bloomberg.com
©2022 Bloomberg L.P.
-
Talking Points This Week: Leadership Shock At Nvidia, Earnings Strength, And The Fog Over Hormuz
The Anthropic IPO pricing and first trading day, Nvidia's upcoming earnings, and any fresh signals from Iran will set the tone for the following week.
-
Signature Play: The Classic Cocktail Is Dead. Or Is It?
Classic cocktails are disappearing from India's cocktail menus. But they're still being ordered, taught to bartenders and borrowed from. So, who's really having the last drink?
-
A New Samvat Wishlist: Inclusive Prosperity And Human Development
India has strengthened its economic foundations through infrastructure, digital access and enterprise. Its next growth chapter must deepen productivity, create better livelihoods and widen participation in prosperity.
-
Love, Sex Aur Dhokha: The Audacious Plot To Spy On Jensen Huang
A Taipei dinner, a Singapore chip buyer and a suspected Chinese asset: inside the alleged spy operation that got close to NVIDIA's Jensen Huang.
-
Ten Things I Learnt This Samvat
Patience can be a trap. Cheap stocks can stay cheap. Leverage can wipe you out. What did Samvat 2082 teach us? Niraj Shah writes on 10 lessons from the year gone by.
-
Talking Points This Week: Tech Nerves, FII Buying, And A Faraway Banking Shock
The global markets are not shining this Diwali. The exception in the large markets is, India.
-
Midterm Rally Lasted A Day. The Hard Reality Of A Divided US May Last Two Years | Opinion
Between a contested AI boom, a debt ceiling that arrives in 2027 and a president with every incentive to act alone, the next two years may prove more volatile than the first day's rally suggests.
-
Blue Wave Will Derail the AI Trade but Won't Dismantle the AI Era | Unhedged Position
The Democrats' sweep of the US Congress will see politics collide with economic forces both over the long and short term.
-
It's Time To Take The GST Council's Bet On Trust Global
Payment records can prove India's services exports, and clear, proportionate rules can bring foreign digital sellers into the tax net.
-
Opinion | India at 38: From Innovation Overperformer to Innovation Powerhouse
India now has 453 VC-backed deep science startups, 18 of them late-stage, after 117 percent growth since 2020. Laurus Labs, at USD 9.3 billion, is the most valuable deep science company in any middle-income economy outside China.
